CytomX Therapeutics
CTMX
CTMX
111 hedge funds and large institutions have $561M invested in CytomX Therapeutics in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 40 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% less funds holding
Funds holding: 122 → 111 (-11)
20% less capital invested
Capital invested by funds: $698M → $561M (-$137M)
38% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 26
Holders
111
Holding in Top 10
1
Calls
$169K
Puts
$2K
Top Buyers
| 1 | +$32.5M | |
| 2 | +$13.7M | |
| 3 | +$4.48M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$3.74M |
| 5 |
AG
Artal Group
Luxembourg
|
+$2.27M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$12.4M | |
| 3 | -$6.67M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$6.17M |
| 5 |
CC
Casdin Capital
New York
|
-$3.84M |